Sophia Genetics SA
SOPHCIK 0001840706 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
63,479 bought / 159,808 sold
net −96,329 sh · −$703.2K
- buys
- 2
- sells
- 16
- insiders active
- 8
Filing tape
Filed Wed, Jul 8, 2026
- −17,685 sh · $93.3K
Camblong Jurgi — Executive Chairman · Director
- Sold17,685Ordinary Shares@ $5.28→ 3,541,122 held
Filed Tue, Jul 7, 2026
- −1,592 sh · $8.4K
Cardoza George — Chief Financial Officer
- Sold1,592Ordinary Shares@ $5.29→ 309,092 held
- −4,241 sh · $21.4K
Valente Manuela — Chief People Officer
- Sold4,241Ordinary Shares@ $5.05→ 210,450 held
- −5,285 sh · $27.0K
Verma Abhimanyu — Chief Technology Officer
- Sold5,285Ordinary Shares@ $5.10→ 192,171 held
- −7,393 sh · $38.2K
Xu Zhenyu — Chief Scientific Officer
- Sold7,393Ordinary Shares@ $5.17→ 614,887 held
- −9,838 sh · $51.4K
Muken Ross — Chief Executive Officer · Director
- Sold9,838Ordinary Shares@ $5.22→ 670,651 held
- −216 sh · $1.1K
Puylaert Kevin — Chief Sales Officer
- Sold138Ordinary Shares@ $5.03→ 148,026 held
- Sold47Ordinary Shares@ $5.03→ 147,979 held
- Sold31Ordinary Shares@ $5.09→ 147,948 held
- −7,393 sh · $38.2K
Menu Philippe — Chief Medical Officer
- Sold7,393Ordinary Shares@ $5.16→ 233,387 held
- −22,486 sh · $118.2K
Camblong Jurgi — Executive Chairman · Director
- Sold22,486Ordinary Shares@ $5.26→ 3,558,807 held
Filed Wed, Jul 1, 2026
- −20,200 sh · $306.1K
Camblong Jurgi — Executive Chairman · Director
- Exercised18,060Ordinary Shares@ $3.16→ 3,619,553 held
- Sold18,060Ordinary Shares@ $5.87→ 3,601,493 held
- Sold350Ordinary Shares@ $6.00→ 3,601,143 held
- Exercised45,419Ordinary Shares@ $3.16→ 3,646,562 held
- Sold45,419Ordinary Shares@ $6.14→ 3,601,143 held
- Sold19,650Ordinary Shares@ $6.02→ 3,581,493 held
- Sold200Ordinary Shares@ $6.30→ 3,581,293 held
- Exercised18,060Share Option (Right to Buy)→ 50,000 held
- Exercised45,419Share Option (Right to Buy)→ 4,581 held
Insiders on this tape
- Camblong JurgiExecutive Chairman · Director
- Cardoza GeorgeChief Financial Officer
- Valente ManuelaChief People Officer
- Verma AbhimanyuChief Technology Officer
- Xu ZhenyuChief Scientific Officer
- Muken RossChief Executive Officer · Director
- Puylaert KevinChief Sales Officer
- Menu PhilippeChief Medical Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.